Compass Therapeutics, Inc. Annual Depreciation in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Compass Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2021 to 2023.
  • Compass Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $200K, unchanged year-over-year.
  • Compass Therapeutics, Inc. annual Depreciation for 2023 was $700K, a 12.5% decline from 2022.
  • Compass Therapeutics, Inc. annual Depreciation for 2022 was $800K, a 33.3% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $700K -$100K -12.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $800K +$200K +33.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $600K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.